Clinical Trial Update: Autologous Bulbar Olfactory Ensheathing Cells and Nerve Grafts for Treatment of Patients With Spinal Cord Transection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for autologous bulbar olfactory ensheathing cells and nerve grafts in spinal cord injury (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury
• Spinal Cord Transection

Drugs mentioned

• autologous bulbar olfactory ensheathing cells and nerve grafts (autologous bulbar olfactory ensheathing cells and nerve grafts)

Snippet

Sponsor: Nicholls Spinal Injury Foundation | Conditions: Spinal Cord Injury at C5-Th10 Level With Complete Lesion, Spinal Cord Transection | Phase 1, Phase 2 | Status: UNKNOWN